ICTR continually updates the pilot awards program to include new initiatives and funding opportunities, including our Novel Methods in Translational Science Pilot Award and Supplements for Dissemination activities. Below is information about our current award programs. The ICTR Pilot Awards Program incorporates the T0 to T4 research classifications. Targeted research areas will continue to include basic discovery research, patient-based clinical research, patient-centered outcomes research, dissemination and implementation research, and community engaged research.
We also offer four career development awards, the KL2 Scholars Program, the TL1 Postdoctoral Training Program, the TL1 Predoctoral Training Program, and the AHEAD Pilot Awards Program. More information about those awards can be found here.
Oct 12, 2021: Please note, all pilot awards are contingent upon successful renewal of grant support for the portfolio of translational research resources ICTR administers.
This is an accordion element with a series of buttons that open and close related content panels.
Clinical & Community Outcomes Research (CCOR) Award - LOI Due Jan 14, 2022
Status: Open RFA
Letter of Intent Due Date: January 14, 2022 by 5 pm CST
Application Due Date: March 11, 2022 by 5 pm CST
Earliest Grant Start Date: July 1, 2022
Mandatory Grant Workshop: TBA
Contact: Kate Judge, kjudge@wisc.edu
Summary of Terms: Up to $75,000 for 12 months of direct support
2022 CCOR RFA
2022 CCOR Application Forms
Goal: To support excellent, community-partnered health research that solves problems translating knowledge into improvements in clinical practice, community programs and health policy. This pilot award may also support the development of interventions that require individual, organizational, or system behavior change.
We welcome applications that address contemporary and(or) emerging health crises and/or disparities in health among high-risk populations including underrepresented racial and ethnic groups.
Deliverable: The successful grantee will use pilot data to seek further, external peer-reviewed funding in support of a research career trajectory. This award is not intended to support a project that is independent of an investigator’s career path.
Helpful reference articles:
- Thabane et al. (2010). A tutorial on pilot studies: the what, why and how. BMC Medical Research Methodology. 10(1):1-10.
- Arain et al. (2010). What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Medical Research Methodology. 10(67):1-7.
- Kistin & Silverstein. (2010). Pilot studies: A critical but potentially misused component of interventional research. JAMA. 314(15):1561-1562.
Collaborative Health Equity Research (CHER) - LOI Due Jan 14, 2022
Status: Open RFA
Letter of Intent Due Date: January 14, 2022 by 5 pm CST
Application Due Date: March 11, 2022 by 5 pm CST
Earliest Grant Start Date: July 1, 2022
Mandatory Grant Workshop: TBA
Contact: Kate Judge, kjudge@wisc.edu
Summary of Terms: Up to $75,000 for 12 months of direct support
2022 CHER RFA
2022 CHER Application Forms
Goal: To support new community-engaged research projects focused on health disparities/inequities wherein the PI is an early stage investigator, e.g., assistant professor, and a senior co-investigator is engaged to ensure a mentored experience and to connect the research team with relevant stakeholders.
Deliverable: Projects are intended to provide preliminary data for a subsequent funding mechanism.
Dissemination & Implementation (D&I) Research Award - LOI Due Jan 14, 2022
Status: Open RFA
Letter of Intent Due Date: January 14, 2022 by 5 pm CST
Application Due Date: March 11, 2022 by 5 pm CST
Earliest Grant Start Date: July 1, 2022
Mandatory Grant Workshop: TBA
In addition to the grant workshop, applicants are required to schedule a 60-minute consultation with the ICTR D&I Launchpad during the early stages of your proposal development. Those who submit a Letter of Intent will receive information about how to sign-up for your consultation. Questions? Email: di-launchpad@ictr.wisc.edu
Contact: Kate Judge, kjudge@wisc.edu
Summary of Terms: Up to $150,000 for 18 months of direct support
2022 D&I RFA
2022 D&I Application Forms
Goal: To support research that addresses how to best ensure that evidence-based or evidence-informed strategies, interventions, and programs are effectively delivered in clinical and community health practice settings and impact policy.
We welcome applications that address contemporary and(or) emerging health crises and/or disparities in health among high-risk populations including underrepresented racial and ethnic groups.
Deliverable: The successful grantee will use the results of this award to seek further extramural peer-reviewed funding for the research.
Evidence to Implementation Award (E2I) - Deadline Passed
Status: Active/RFA Closed
Required Workshop (Asynchronous): Available Nov 2, 2020, https://videos.med.wisc.edu/videos/99893
Pre Proposal Receipt Date: Nov 30, 2020
Mandatory D&I Project Analysis Meetings: Dec 2020 – Jan 2021
Final Application Date: Jan 22, 2021
Grant Start Date: March 2021
Contact: Mondira Saha-Muldowney, mondira.sahamuldowney@wisc.edu
Summary of Terms: Up to $52,500 for 12 months of direct support
2020 E2I RFA Application (10/30/2020 Update)
Goal: The purpose of the E2I award is to expedite dissemination of evidence based practices, interventions, and innovations to appropriate end-users using the D&I Launchpad Program. These include self-management or other health promotion workshops and interventions, and health services innovations that improve delivery of care in the health care or community setting.
Deliverable: This award supports the creation of a Launchpad Package to support the dissemination and implementation of the evidence-based intervention or innovation. The elements of the Launchpad Package will be unique to each project, but may include a business plan – value proposition, marketing, sales, financials, intellectual property review, and the necessary tools and materials to support it.
Novel Methods in Translational Science Award - LOI Due Nov 19, 2021
formerly known as the Novel Methods Award
Status: Active
Letter of Intent Receipt Date: Nov 19, 2021 by 5 pm CST
Application Due Date: Dec 20, 2021 by 5 pm CST
Contact: Before submitting this LOI, contact Peggy Hatfield, pmhatfie@wisc.edu.
Summary of Terms: Up to $50,000 for 12 months of direct support
2021 Novel Methods RFA
2021 Novel Methods Application Forms
The goal of this RFA is to support innovative processes and methods to advance translation across the research spectrum. The proposed method should NOT be solely project-specific; successful methods will be generalizable to other projects. Methods also must be truly novel, but not novel applications of existing methods. Applicants will choose one of three tracks to submit their grant proposal. We will fund at least one award per track, provided the applications are scientifically meritorious.
Stakeholder & Patient Engaged Research (SPER) - LOI Due Jan 14, 2022
Status: Open RFA
Letter of Intent Due Date: January 14, 2022 by 5 pm CST
Application Due Date: March 11, 2022 by 5 pm CST
Earliest Grant Start Date: July 1, 2022
Mandatory Grant Workshop: TBA
Contact: Kate Judge, kjudge@wisc.edu
Summary of Terms: Up to $100,000 for 12 months of direct support
2022 SPER RFA
2022 SPER Application Forms
Goal: The Stakeholder and Patient Engaged Research (SPER) RFA provides support for activities that will strengthen a competitive application for external funding for research requiring strong stakeholder engagement methodology as a foundation for a success.
We welcome applications that address contemporary and(or) emerging health crises and/or disparities in health among high-risk populations including underrepresented racial and ethnic groups.
Deliverable: The deliverable for this award is a subsequent application to an external funder including, but not limited to, the following:
Translational Basic & Clinical Research Pilot Award - LOI Due Dec 20, 2021
Status: Active
Letter of Intent Receipt Date: Dec 20, 2021, by 5 pm CST
Application Due Date: Feb 21, 2022, by 5 pm CST
Grant Start Date: July 1, 2022
Mandatory Letter of Intent: Please submit to Peggy Hatfield, pmhatfie@wisc.edu
Summary of Terms: Up to $50,000 for 12 months of direct support
2021 Translational Basic & Clinical Research RFA
2021 Translational Basic & Clinical Research Pilot Application Forms
These awards address translational basic discovery activities (biological, social, behavioral mechanisms that underlie disease); development of biomarkers, target and lead molecules, and devices (mechanical, computational); preclinical and animal models; and translation of discovery to patients (new diagnostic, treatment, and prevention methods; Phase 1 and Phase 2 clinical trials).
*NEW for 2021* Pilot applications MUST have two PIs from different scientific disciplines. Differences will be inferred from areas of specialization and/or degree training or departmental affiliation.
Additional Requirements and Information
- PIs or Co-PIs can only apply to a single ICTR Pilot RFA per funding cycle.
- Health Equity Research Resources
- ICTR-CAP Directory of Programs (PDF)
- Key Terms for Community Engaged Research (PDF)
- NIH Biosketch Format
- NIH Definition of a Clinical Trial (Nov 1, 2017)
- Non-Supplanting Questionnaire (Word Doc)
- Research Grant Terms & Conditions
- Review Process for Community-Engaged Research (Word Doc)